Tenaya Therapeutics (TNYA) Cash from Investing Activities (2020 - 2026)

Tenaya Therapeutics' Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$11000.0 for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 100.05% year-over-year to -$11000.0; the TTM figure through Mar 2026 stood at $33.8 million (up 20.94% YoY), while the FY2025 annual figure was $56.1 million, up 4858.71% from the prior year.
• Cash from Investing Activities was -$11000.0 for Q1 2026 at Tenaya Therapeutics, up from -$67000.0 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $31.0 million in Q3 2022 to a low of -$30.1 million in Q3 2024.
• Historically, Cash from Investing Activities has averaged $11.2 million across 5 years, with a median of $14.1 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities soared 1033.56% in 2022, then slumped 349.73% in 2023.
• A 5-year view of Cash from Investing Activities shows it stood at $6.0 million in 2022, then plunged by 349.73% to -$14.9 million in 2023, then surged by 194.53% to $14.1 million in 2024, then plunged by 100.48% to -$67000.0 in 2025, then soared by 83.58% to -$11000.0 in 2026.
• The last three Cash from Investing Activities figures came in at -$11000.0 (Q1 2026), -$67000.0 (Q4 2025), and $8.9 million (Q3 2025), per Business Quant data.